Apoptosis modulators in the therapy of neurodegenerative diseases

By Deigner H-P.   Haberkorn U.   Kinscherf R.  

Expert Opinion on Investigational Drugs, Vol. 9, Iss. 4, 2000-04 ,pp. : 747-764

Informa Healthcare

Access to resources Recommend Favorite

Editorial [Hot Topic: Advances and Perspectives on Stem Cell Therapy for Human Neurodegenerative Diseases (Guest Editor: Liang-Wei Chen)]

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 10, Iss. 4, 2011-06 ,pp. : 417-418

Bentham Science Publishers

Access to resources Recommend Favorite

Commentary: Intravenous Immunoglobulin (IVIG) Therapy for Patients with Langerhans Cell Histiocytosis (LCH)-Related Neurodegenerative Diseases of the CNS

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 14, Iss. 6, 2015-08 ,pp. : 688-690

Bentham Science Publishers

Access to resources Recommend Favorite

Nanotechnology and Antioxidant Therapy: An Emerging Approach for Neurodegenerative Diseases

By  

Current Medicinal Chemistry, Vol. 21, Iss. 38, 2014-12 ,pp. : 4311-4327

Bentham Science Publishers

Access to resources Recommend Favorite

Human Embryonic Stem Cell Therapies for Neurodegenerative Diseases

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 10, Iss. 4, 2011-06 ,pp. : 440-448

Bentham Science Publishers

Access to resources Recommend Favorite